NCT05708040View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy of the Smart Insulin Pen Compared to a Closed Loop System in Patients With Type 1 Diabetes (EBIACE-1)

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 19, 2022

Primary Completion Date

January 27, 2023

Study Completion Date

January 27, 2023

Conditions
Type1diabetes
Interventions
DEVICE

InPen Medtronic

Patients with DM1 ≥ 18 years of age who initiate Inpen system.

DEVICE

Minimed 780G system

Patients with DM1 ≥ 18 years of age who initiate Minimed 780G system.

Trial Locations (1)

28034

Hospital Universitario Ramón y Cajal, Madrid

All Listed Sponsors
lead

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

OTHER